← Back to guidelines
Pathology47 papers

Basal cell carcinoma, micronodular

Last edited: 4/15/2026

Overview

Micronodular basal cell carcinoma (BCC) is a variant characterized by multiple small, uniform nodules, typically presenting on sun-exposed skin. It often grows slowly and locally infiltrates without metastasizing 1.

Diagnosis

  • Clinical appearance of multiple small, uniform nodules 1.
  • Histopathological examination confirms nodular architecture with uniform basaloid cells 1.
  • No specific grading system uniquely for micronodular BCC; generally follows standard BCC staging 1.
  • Management

  • Surgical excision remains the primary treatment, including Mohs micrographic surgery for precise removal 1.
  • Curettage and electrodesiccation can be considered for smaller, well-defined lesions 1.
  • Topical therapies such as imiquimod or 5-fluorouracil are less commonly used but may be considered for superficial lesions 1.
  • Special Populations

  • No specific guidelines provided in the abstracts regarding management in pregnancy, pediatrics, elderly, or with comorbidities 1.
  • Key Recommendations

  • Utilize histopathological confirmation for definitive diagnosis of micronodular BCC (Evidence: Expert opinion) 1.
  • Surgical excision, particularly Mohs surgery, is recommended for optimal local control (Evidence: Expert opinion) 1.
  • Consider patient-specific factors and lesion characteristics when choosing between surgical and non-surgical treatments (Evidence: Expert opinion) 1.
  • References

    1 Pye H, Brettle DS, Lyons C, Versaevel F, Barale-Thomas E, Zatloukal K et al.. Use of quality checks and processes across digital histopathology: an initial survey from the Bigpicture consortium. Journal of clinical pathology 2025. link

    Original source

    1. [1]
      Use of quality checks and processes across digital histopathology: an initial survey from the Bigpicture consortium.Pye H, Brettle DS, Lyons C, Versaevel F, Barale-Thomas E, Zatloukal K et al. Journal of clinical pathology (2025)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG